The NTIS website and supporting ordering systems are undergoing a major upgrade from 8PM on September 25th through approximately October 6. During that time, much of the functionality, including subscription and product ordering, shipping, etc., will not be available. You may call NTIS at 1-800-553-6847 or (703) 605-6000 to place an order but you should expect delayed shipment. Please do NOT include credit card numbers in any email you might send NTIS.
Documents in the NTIS Technical Reports collection are the results of federally funded research. They are directly submitted to or collected by NTIS from Federal agencies for permanent accessibility to industry, academia and the public.  Before purchasing from NTIS, you may want to check for free access from (1) the issuing organization's website; (2) the U.S. Government Printing Office's Federal Digital System website; (3) the federal government Internet portal; or (4) a web search conducted using a commercial search engine such as
Accession Number ADA583308
Title Genetic Interaction Screen for Breast Cancer Progression Driver Genes.
Publication Date Jun 2013
Media Count 6p
Personal Author T. Xu
Abstract Breast cancer is the most common malignant cancer among American women and the second leading cause of cancer death in women. The analysis of genetic alterations in human breast cancers has revealed that individual tumors accumulate mutations in approximately ninety different genes. However, the significance of most mutations to cancer development remains unknown. The ability to differentiate between driver and bystander mutations will provide valuable insight into how breast cancers develop and how to tailor individualized strategies for the diagnosis and treatment of cancer. We performed a screen to test the roles of seventy breast cancer mutated genes in mouse mammary tumorigenesis using the MMTV-PyVT mouse breast cancer model and piggyBac insertional mutation strains. We found that insertional mutations in 23 genes altered the onset of tumor formation and four genes exacerbated tumor metastasis. Among the 23 genes, Trim33 and Ahrr, have been recently reported as tumor suppressors, demonstrating the effectiveness of our screen. We have further confirmed the oncogenic roles of two metabolism related genes, Grik3 and HadHB with in vitro tumor assays and are currently performing mechanistic studies. The next phase of questions will be focused on how disruption of metabolism contributes to tumor development and progression.
Keywords Breast cancer
Cancer screening
Driver mutations
In vitro analysis

Source Agency Non Paid ADAS
NTIS Subject Category 57F - Cytology, Genetics, & Molecular Biology
57E - Clinical Medicine
Corporate Author Yale Univ., New Haven, CT. School of Medicine.
Document Type Technical report
Title Note Annual rept. 1 Jun 2012-31 May 2013.
NTIS Issue Number 1401
Contract Number W81XWH-12-1-0082

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader